Clinical trial
A Randomized, Double-blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease
NCT01384747 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind Study of Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2011
- Completion date
- March 31, 2018
- Enrollment
- 186 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.